Xueyan Wang
Anhui University(CN)
Publications by Year
Research Areas
Fibroblast Growth Factor Research, Epigenetics and DNA Methylation, Ubiquitin and proteasome pathways, RNA modifications and cancer, Microbial Community Ecology and Physiology
Most-Cited Works
- SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types.(1999)
- → Separating Tumorigenicity from Bile Acid Regulatory Activity for Endocrine Hormone FGF19(2014)178 cited
- → MBX-8025, A Novel Peroxisome Proliferator Receptor-δ Agonist: Lipid and Other Metabolic Effects in Dyslipidemic Overweight Patients Treated with and without Atorvastatin(2011)147 cited
- → Extracellular Signal–Regulated Kinase 1/2 Mitogen-Activated Protein Kinase Pathway Is Involved in Myostatin-Regulated Differentiation Repression(2006)139 cited
- → SU14813: a novel multiple receptor tyrosine kinase inhibitor with potent antiangiogenic and antitumor activity(2006)103 cited
- → Casein Kinase II Increases the Transcriptional Activities of MRF4 and MyoD Independently of Their Direct Phosphorylation(1996)85 cited
- → Effects of the PPAR-δ agonist MBX-8025 on atherogenic dyslipidemia(2011)75 cited
- → Ketogenic diet prevents chronic sleep deprivation-induced Alzheimer’s disease by inhibiting iron dyshomeostasis and promoting repair via Sirt1/Nrf2 pathway(2022)55 cited
- → The transcription factor RFX5 is a transcriptional activator of the TPP1 gene in hepatocellular carcinoma(2016)49 cited
- → SARS-CoV-2 pseudovirus enters the host cells through spike protein-CD147 in an Arf6-dependent manner(2022)46 cited